Updated: January 20, 2026
How to Help Your Patients Find Nurtec ODT in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
- Why Nurtec ODT Prescriptions Get Abandoned
- Step 1: Maximize Your PA Documentation at the Time of Prescribing
- Step 2: Connect Patients With the Pfizer Support Programs at the Appointment
- Step 3: Give Patients a Clear Action Plan for Pharmacy Issues
- Step 4: For Preventive Use — Set Expectations Around Dosing and Refills
- Step 5: Know When to Switch — And What to Switch To
- The Bottom Line for Providers
A practical guide for providers on helping patients locate Nurtec ODT in stock, navigate insurance hurdles, and use Pfizer support resources to minimize prescription abandonment.
Prescribing Nurtec ODT (rimegepant) to your migraine patients is only half the battle. The other half is making sure they can actually get it filled. Between prior authorization requirements, high cash prices, and inconsistent pharmacy stocking, a significant number of Nurtec prescriptions go unfilled — a phenomenon known as prescription abandonment that represents a real clinical problem for patients who need consistent migraine management.
This guide provides practical tools and workflows to help your patients successfully access Nurtec ODT and minimize the gap between your prescription and their pharmacy pickup.
Why Nurtec ODT Prescriptions Get Abandoned
Understanding the failure points in the access pathway helps you proactively address them at the time of prescribing:
Prior Authorization rejection or delay: The most common issue. Insurers require documentation of triptan failure or contraindications before covering Nurtec. Incomplete PA submissions are a leading cause of delays.
High copay or cost shock: Patients without the copay card may face sticker shock at $1,000+ retail pricing and walk away from the counter. Many are unaware of the $0 copay card available for eligible commercially insured patients.
Pharmacy doesn't have it in stock: Nurtec is a specialty brand that not every pharmacy stocks routinely. Patients may be told "we don't carry that" and not know to ask the pharmacy to order it.
Patient confusion about insurance denial vs. stock issues: Patients often can't tell the difference. A clear message from your team helps them take the right action.
Step 1: Maximize Your PA Documentation at the Time of Prescribing
The single most impactful thing you can do is submit a complete, well-documented PA at the time you prescribe. Incomplete or generic PA letters significantly increase turnaround time and rejection rates.
Your PA letter should include:
Migraine diagnosis with ICD-10 code (G43.009 for episodic without aura; G43.109 for with aura)
Monthly headache days (specify episodic: 1–14/month)
Specific triptans tried (drug name, dose, duration), with documented reason for failure: inadequate response, intolerable side effects, or cardiovascular/other contraindication
For preventive use: prior preventive medication history and clinical rationale for Nurtec over other preventives
Functional impact documentation (MIDAS, HIT-6, or narrative about impairment in work/daily activities)
Step 2: Connect Patients With the Pfizer Support Programs at the Appointment
Before the patient leaves your office, ensure they know about these Pfizer access resources:
Nurtec Copay Card (nurtec.com/savings): Eligible commercially insured patients can pay as little as $0 per fill (up to $7,000/year). Have your medical assistant hand the patient the URL or a printed card.
Bridge Benefit: One-time access to up to 16 tablets at no cost while PA is verified. Patients can activate this through the copay card portal or via Pfizer's Patient Access Coordinators at 866-222-4183.
Pfizer Patient Assistance Program: For uninsured/underinsured patients meeting income criteria. Annual reauthorization required.
Step 3: Give Patients a Clear Action Plan for Pharmacy Issues
Many patients give up when they encounter a pharmacy problem. A short handout or verbal guidance can help:
"If the pharmacy says they don't have it: ask them to order it. They can get it in 24–48 hours from their distributor."
"If your insurance denied the claim: call our office at [number] — we will initiate a PA for you."
"If you can't find it nearby: use medfinder — they call pharmacies near you to check stock and text you the results."
Step 4: For Preventive Use — Set Expectations Around Dosing and Refills
When prescribing Nurtec for prevention (every other day dosing), patients need approximately 15 tablets per month. Many pharmacies dispense in 8-tablet packs, requiring two packs per fill for a full preventive month. Insurance quantity limits may also affect this.
Consider specifying the preventive dosing regimen explicitly on the prescription — "1 tablet orally every other day for preventive migraine treatment" — to ensure the correct quantity is dispensed and to minimize PA denials related to dosing confusion.
Step 5: Know When to Switch — And What to Switch To
If access barriers are persistent and a patient has gone more than 2–3 weeks without Nurtec, consider a bridge prescription. Options:
Acute treatment bridge: Generic sumatriptan (widely available, $5–$20) while PA is resolved
Prevention bridge: Short course of propranolol or topiramate (both widely available as generics) if Nurtec preventive access is delayed
Long-term alternative: Qulipta (atogepant) or CGRP mAb injection if Nurtec access cannot be resolved
For more on the clinical alternatives available in 2026, see Nurtec ODT shortage: what providers need to know.
The Bottom Line for Providers
Nurtec ODT is a high-value medication for your migraine patients — but it requires active access management. Proactive PA submissions, copay card counseling, and clear patient guidance at the point of prescribing are the most effective tools you have. For a quick and scalable pharmacy availability check option for your patients, recommend medfinder for providers.
Frequently Asked Questions
The most effective approach combines three actions at the time of prescribing: (1) submit a complete, well-documented prior authorization immediately; (2) connect the patient with the Pfizer copay card and bridge benefit; (3) give the patient a clear action plan for pharmacy issues, including how to ask for a special order and how to use medfinder to find stock.
Most commercial PA decisions are returned within 3–7 business days when documentation is complete. Urgent PA requests for patients with significant functional impairment can sometimes be processed in 24–72 hours. Incomplete submissions or appeals can extend this timeline to several weeks.
Yes. Nurtec ODT is the only FDA-approved medication for both acute treatment and prevention of episodic migraine. For acute use, the dose is 75 mg as needed (max once daily, up to 18 doses/30 days). For prevention, it's 75 mg every other day. Some plans may require separate PA approvals for each indication, so document both use cases in your PA letter.
Tell your patient to ask the pharmacist to place a special order for Nurtec ODT — most pharmacies can receive it from their wholesale distributor within 24–48 hours. They can also use medfinder to locate a nearby pharmacy that has it in stock. If cost is the barrier, direct them to nurtec.com/savings for the Pfizer copay card.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Nurtec ODT also looked for:
More about Nurtec ODT
29,999 have already found their meds with Medfinder.
Start your search today.





